Summary of Product Characteristics Updated 01-Nov-2021 | SANOFI Consumer Healthcare
Dioralyte Relief Blackcurrant
Dioralyte Relief Blackcurrant & Raspberry
Dioralyte Relief Raspberry & Blackcurrant
Dioralyte Double Action Blackcurrant
(See section 6.5 for pack details)
Active ingredients per sachet:
Pre-cooked Rice Powder
Sodium Citrate PhEur
Sodium Chloride PhEur
Potassium Chloride PhEur
Sachet containing powder for mixing with water prior to administration.
For the treatment of fluid and electrolyte loss associated with acute diarrhoea.
Adults and children:
One sachet after every loose motion up to a maximum of 5 sachets per day for 3-4 days.
Infants from 3 months to one year under medical advice:
In the event of diarrhoea and depending on the extent of dehydration (loss of weight assessed at less than 10%) 150 to 200 ml/kg/24 hours of preparation may be given.
• half the volume is to be given during the first 8 hours, and the other half during the next 16 hours.
• in the event of vomiting accompanying the diarrhoea, the amount administered can be divided up (5 to 10 ml every 5 minutes) and this may be gradually increased until the infant can drink normally.
Method of Administration
Pour the contents of one sachet into a large glass. Add 200ml of drinking water Mix well until the liquid has a milky appearance and drink the whole glassful. Ensure that no solid is remaining at the bottom of the glass and do not use extra water to rinse out the glass. For infants and where drinking water is not available, the water should be freshly boiled and cooled. The solution should be made up immediately before use.
Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Dioralyte Relief Blackcurrant should not be used in patients with phenylketonuria. However, there may be a number of conditions where treatment with Dioralyte Relief Blackcurrant may be inappropriate, e.g. intestinal obstruction requiring surgical intervention, cases of severe renal or hepatic impairment.
For oral administration only. Dioralyte Relief should not be reconstituted in diluents other than water.
Each sachet should always be dissolved in 200ml water.
Dioralyte Relief should not be administered to infants under 3 months and for those aged 3 months to 1 year, administered under medical advice.
Infants under the age of 2 with diarrhoea should be seen by the physician as soon as possible.
If diarrhoea persists unremittingly for longer than 36 hours the patient should be reassessed by the physician.
No specific precautions are necessary in the elderly. However, care should be taken when administering Dioralyte Relief solution in conditions where normal electrolyte balance may be disturbed (such as severe vomiting or diarrhoea). Dioralyte Relief should not be used for self-treatment by patients on low potassium or sodium diets.
The use of Dioralyte Relief in patients with the following conditions should be supervised by a physician:
• On low potassium or low sodium diets.
This medicine contains 190 mg sodium (main component of cooking/table salt) in each sachet, equivalent to 10 % of the WHO recommended maximum daily dietary intake of 2g of sodium for an adult.
Dioralyte Relief is not contraindicated in pregnancy or lactation but should be used on medical advice.
There is limited data available on the use of Dioralyte Relief in pregnant women. However, no conclusions can be drawn whether Dioralyte Relief is safe for use during pregnancy or not. Dioralyte Relief should be used during pregnancy only if the potential benefits to the mother outweigh the potential risks, including those to the fetus.
There is limited data available on the presence of Dioralyte Relief in human milk, milk production, or the effects on the breastfed infant. However, no conclusions can be drawn whether Dioralyte Relief is safe for use during breastfeeding or not. Dioralyte Relief should be used during breastfeeding only if the potential benefits to the mother outweigh the potential risks, including those to the breastfed child.
Dioralyte Relief could not be expected to affect the ability to drive or use machines.
The information below lists reported adverse reactions, ranked using the following frequency classification:
Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data).
Immune system disorders
Not known: Hypersensitivity
Reporting of suspected adverse reactions
Reporting suspected adverse reaction after authorisation of the medicinal product is important. It allows continued monitoring of the benefit / risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard search for MHRA Yellow Card in the Google Play or Apple App Store.
In the event of significant overdose, serum electrolytes should be evaluated as soon as possible, appropriate steps taken to correct any abnormalities and levels monitored until return to normal levels is established. This is particularly important in the very young and in cases of severe hepatic or renal failure.
Dioralyte Relief contains a balanced amount of electrolytes, starch and proteins in water. Oral rehydration therapy with Dioralyte Relief enables a dehydrated subject to be rehydrated rapidly. The presence of pre-cooked rice in the formulation enables watery stools to return to normal more rapidly.
The advantages of Dioralyte Relief are bound with its composition.
• Water: the appropriate amount is essential to correct dehydration.
• Starch: low osmotic capacity (unlike pure glucose) thus preventing any additional loss of fluid through the stools. Rice starch contains 20% amylose and 80% amylopectin.
• Proteins: specific nutritional properties.
• Electrolytes: essential for restoring the ionic equilibrium. The role of citrate is to correct the acidosis that occurs as a result of diarrhoea. Citrate also enhances the absorption of Na+ and is more stable than bicarbonate.
Content of electrolytes in the reconstituted preparation:
10 mmol/l (or 30 meq/l)
Blackcurrant Flavour Firmenich 501017
A shelf life of 36 months is given for unopened sachets of the product when stored under the conditions given in section 6.4. Once reconstituted, any solution should be used within one hour, or within 24 hours if stored in a refrigerator.
Store in a dry place under 25°C.
Carton containing paper/PVDC sachets of Dioralyte Relief Blackcurrant powder. Dioralyte Relief Blackcurrant is available in packs of 6 or 20 sachets.
Dioralyte Relief Blackcurrant & Raspberry is available as a pack of 6 sachets containing:
4 sachets blackcurrant flavour, 2 sachets raspberry flavour*
Dioralyte Relief Raspberry & Blackcurrant is available as a pack of 6 sachets containing:
4 sachets raspberry flavour*, 2 sachets blackcurrant flavour
(*, raspberry formulation PL 04425/0280).
See section 4.2 for instructions on reconstitution.
Opella Healthcare UK Limited, trading as Sanofi
410 Thames Valley Park Drive,
410, Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
+44 (0)800 035 2525
+44 (0)118 354 3000